Development and validation of a radiomics nomogram for progression-free survival prediction in stage IV EGFR-mutant non-small cell lung cancer

	Development and validation of a radiomics nomogram for progression-free survival prediction in stage IV EGFR-mutant non-small cell lung cancer
	Song, Jiangdian 1,2; Zang, Yali2 ; Li, Weimin 3; Zhong, Wenzhao 4; Shi, Jingyun 6; Dong, Di2 ; Liu, Zaiyi 5; Tian, Jie 2
	2017
会议名称	SPIE Medical Imaging
会议录名称	SPIE Medical Imaging 2017
会议日期	2017-02
会议地点	Orlando, Florida USA
摘要	Accurately predict the risk of disease progression and benefit of tyrosine kinase inhibitors (TKIs) therapy for stage IV non-small cell lung cancer (NSCLC) patients with activing epidermal growth factor receptor (EGFR) mutations by current staging methods are challenge. We postulated that integrating a classifier consisted of multiple computed tomography (CT) phenotypic features, and other clinicopathological risk factors into a single model could improve risk stratification and prediction of progression-free survival (PFS) of EGFR TKIs for these patients.
关键词	Radiomics
文献类型	会议论文
条目标识符	http://ir.ia.ac.cn/handle/173211/12494
专题	中国科学院分子影像重点实验室
通讯作者	Zang, Yali; Tian, Jie
作者单位	1.Sino-Dutch Biomedical and Information Engineering School, Northeastern University 2.Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences 3.West China Hospital, Chengdu, 610041, China 4.Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences 5.Department of radiology, Guangdong General Hospital 6.Department of radiology, Shanghai Pulmonary Hospital
第一作者单位	中国科学院自动化研究所
通讯作者单位	中国科学院自动化研究所
推荐引用方式 GB/T 7714	Song, Jiangdian,Zang, Yali,Li, Weimin,et al. Development and validation of a radiomics nomogram for progression-free survival prediction in stage IV EGFR-mutant non-small cell lung cancer[C],2017.

条目包含的文件
文件名称/大小	文献类型	版本类型	开放类型	使用许可
2017.SPIEMI.SongJian（98KB）	会议论文		开放获取	CC BY-NC-SA	浏览